Images

Filter by

Figure 1 Myocardial Stunning Hibernating Myocardium and Myocardial Scar
Figure 1: Myocardial Stunning, Hibernating Myocardium and Myocardial Scar
Table 3 Attitudes and Perception on Prerequisite Evidence Felt Necessary Prior to Marketing a Polypill to Manage Heart Failure
Table 3: Attitudes and Perception on Prerequisite Evidence Felt Necessary Prior to Marketing a Polypill to Manage Heart Failure
Table 2 Knowledge Attitudes and Perception Surrounding Prescription of a Polypill in Managing Heart Failure
Table 2: Knowledge, Attitudes and Perception Surrounding Prescription of a Polypill in Managing Heart Failure
Table 1 Demographics of Respondents and Current Clinical Practice in Prescribing Guideline directed Medical Therapy
Table 1: Demographics of Respondents and Current Clinical Practice in Prescribing Guideline-directed Medical Therapy
Figure 2 Heart Failure with Preserved Ejection Fraction Pathophysiology Clinical Manifestations and Possible Sites of Intervention
Figure 2: Heart Failure with Preserved Ejection Fraction Pathophysiology, Clinical Manifestations and Possible Sites of Intervention
Figure 1 Three Heart Failure with Preserved Ejection Fraction Phenotypes
Figure 1: Three Heart Failure with Preserved Ejection Fraction Phenotypes
Figure 3 Investigations Performed for Case 2
Figure 3: Investigations Performed for Case 2
Figure 2 Investigations Performed for Case 1
Figure 2: Investigations Performed for Case 1
Figure 1 Clinical Pathway in the Diagnosis of Cardiac Amyloidosis
Figure 1: Clinical Pathway in the Diagnosis of Cardiac Amyloidosis
Figure 1 All Cardiogenic Shock and Mortality
Figure 1: All Cardiogenic Shock and Mortality
Baseline Characteristics of the Study Cohort
Baseline Characteristics of the Study Cohort
Figure 3  Sequences of Guideline directed Medical Therapy Initiation in Patients with Heart Failure
Figure 3: Sequences of Guideline-directed Medical Therapy Initiation in Patients with Heart Failure